Suppr超能文献

行体外膜肺氧合治疗的难治性心脏手术后心原性休克患者的长期预后。

Long-term outcomes of patients undergoing extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock.

机构信息

Department of Cardiovascular Surgery, Nihon University School of Medicine, 30-1 Ooyaguchi-kami-machi, Itabashi-ku, Tokyo, 173-8610, Japan.

出版信息

Surg Today. 2013 Mar;43(3):264-70. doi: 10.1007/s00595-012-0322-6. Epub 2012 Sep 4.

Abstract

PURPOSE

Postcardiotomy cardiogenic shock is still associated with a poor prognosis. We reviewed patients undergoing extracorporeal membrane oxygenation (ECMO) support for postcardiotomy cardiogenic shock and assessed their long-term outcomes.

METHODS

The subjects were 47 patients who received ECMO support for cardiogenic shock after open heart surgery. We analyzed the long-term survival and risk factors for early or late death.

RESULTS

Twenty-nine patients were weaned off ECMO support, but 15 of these patients died during their hospital stay. An independent predictor of mortality during ECMO support was incomplete sternum closure (OR 4.089, 95 % CL 1.003-16.67, p = 0.049) and a predictor of mortality after weaning off ECMO was more than 48 h of support (OR 8.975, 95 % CL 1.281-62.896, p = 0.027). Fourteen patients were discharged from hospital, but seven of these patients died during the follow-up period owing to cardiac events (n = 2) or non-cardiac causes (n = 5). The actuarial survival rates were 34.0 % at 30 days, 29.8 % at 1 year, and 17.6 % at 10 years.

CONCLUSION

Although postcardiotomy cardiogenic shock requiring ECMO support is associated with high morbidity and mortality, the long-term survival rate is acceptable.

摘要

目的

心脏手术后并发心原性休克仍然与预后不良相关。我们回顾了接受体外膜肺氧合(ECMO)支持治疗心脏手术后心原性休克的患者,并评估了他们的长期结局。

方法

本研究对象为 47 例因开胸手术后心原性休克而接受 ECMO 支持的患者。我们分析了长期生存情况以及早期和晚期死亡的危险因素。

结果

29 例患者成功撤离 ECMO 支持,但其中 15 例患者在住院期间死亡。ECMO 支持期间死亡的独立预测因素是胸骨不完全闭合(OR 4.089,95%CL 1.003-16.67,p=0.049),撤离 ECMO 后死亡的预测因素是支持时间超过 48 小时(OR 8.975,95%CL 1.281-62.896,p=0.027)。14 例患者出院,但由于心脏事件(n=2)或非心脏原因(n=5),在随访期间有 7 例患者死亡。30 天、1 年和 10 年的累计生存率分别为 34.0%、29.8%和 17.6%。

结论

尽管需要 ECMO 支持的心脏手术后心原性休克与高发病率和死亡率相关,但长期生存率是可以接受的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验